Pressmeddelanden
Notice of extra general meeting in Biovica International AB
The shareholders of Biovica International AB, reg. no. 556774-6150, (the "Company") are hereby invited to the extra general meeting on Thursday 2 May 2019 at 13.00 pm CET at Baker & McKenzie's premises at Vasagatan 7 in Stockholm. The doors to the meeting will open at 12.45 pm CET. Right to attend and notification Shareholders […]
Interim Report May-January 2018/2019
Significant events during the third quarter · Abstract was presented at San Antonio Breast Cancer Symposium · New office and staff in USA Significant events after the end of the period · Abstract to be presented at AACR in April · Shares now traded on Nasdaq First North Premier · Lars Holmqvist elected as new Chairman · Two new customers, a pharmaceutical company and a CRO, and sales of SEK 1.5 million.
Report from Biovica’s Extra Shareholder’s Meeting on March 20, 2019
Uppsala, Sweden, March 20, 2019. Lars Holmqvist was elected Chairman of the Board and a warrant program of 175,000 options to the Board was approved.
Report from Biovica’s Annual General Meeting on August 30, 2018
Below is a summary of the decisions taken at the Annual General Meeting, AGM. The Meeting resolved that available funds of SEK 60,768,811 will be carried forward. The Meeting resolved that Board members should be compensated with SEK 125,000 for Directors and SEK 200,000 for the Chairman of the Board. The Meeting also resolved that […]